Through the continued support of Washington Square Health Foundation, funding had been previously provided (see Highlighted Grants 1998 – 1998, “Washington Square in CyberSpaceto the Weizmann Institute of Science to conduct the clinical trial for Dr. Hadassa Degani’s diagnostic imaging technique known as the 3TP method, to detect the presence of benign and malignant tumors of the breast and prostrate without the need for invasive surgical biopsies.
The 3TP method identifies tumors, and is also able to differentiate with certainty between benign and malignant tumors through MRI imaging rather than biopsy.
Based upon these clinical trials, the method has recently received FDA approval. Washington Square Health Foundation is continuing to support the Weizmann Institute’s research to improve the accuracy of diagnoses by integrating the current clinical (physical exam and mammography) methods of detection with this new methodology to show how in a clinical setting the inclusion of the 3TP method will reach an accuracy level of over 98% and meet today’s standard of accuracy, the invasive surgical biopsy. For more information on the process visit the highlighted grants from 1998 – 1999’s section entitled “Washington Square in Cyberspace”